Cargando…
The “discordant doppelganger dilemma”: SGLT2i mimics therapeutic carbohydrate restriction - food choice first over pharma?
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373610/ https://www.ncbi.nlm.nih.gov/pubmed/33564065 http://dx.doi.org/10.1038/s41371-021-00482-y |
| _version_ | 1783739969145143296 |
|---|---|
| author | Murray, Scott W. McKelvey, Sean Heseltine, Thomas D. Henderson, George Singh, Jagdeep Unwin, David Brady, Adrian J. B. |
| author_facet | Murray, Scott W. McKelvey, Sean Heseltine, Thomas D. Henderson, George Singh, Jagdeep Unwin, David Brady, Adrian J. B. |
| author_sort | Murray, Scott W. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8373610 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83736102021-09-02 The “discordant doppelganger dilemma”: SGLT2i mimics therapeutic carbohydrate restriction - food choice first over pharma? Murray, Scott W. McKelvey, Sean Heseltine, Thomas D. Henderson, George Singh, Jagdeep Unwin, David Brady, Adrian J. B. J Hum Hypertens Comment Nature Publishing Group UK 2021-02-09 2021 /pmc/articles/PMC8373610/ /pubmed/33564065 http://dx.doi.org/10.1038/s41371-021-00482-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Comment Murray, Scott W. McKelvey, Sean Heseltine, Thomas D. Henderson, George Singh, Jagdeep Unwin, David Brady, Adrian J. B. The “discordant doppelganger dilemma”: SGLT2i mimics therapeutic carbohydrate restriction - food choice first over pharma? |
| title | The “discordant doppelganger dilemma”: SGLT2i mimics therapeutic carbohydrate restriction - food choice first over pharma? |
| title_full | The “discordant doppelganger dilemma”: SGLT2i mimics therapeutic carbohydrate restriction - food choice first over pharma? |
| title_fullStr | The “discordant doppelganger dilemma”: SGLT2i mimics therapeutic carbohydrate restriction - food choice first over pharma? |
| title_full_unstemmed | The “discordant doppelganger dilemma”: SGLT2i mimics therapeutic carbohydrate restriction - food choice first over pharma? |
| title_short | The “discordant doppelganger dilemma”: SGLT2i mimics therapeutic carbohydrate restriction - food choice first over pharma? |
| title_sort | “discordant doppelganger dilemma”: sglt2i mimics therapeutic carbohydrate restriction - food choice first over pharma? |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373610/ https://www.ncbi.nlm.nih.gov/pubmed/33564065 http://dx.doi.org/10.1038/s41371-021-00482-y |
| work_keys_str_mv | AT murrayscottw thediscordantdoppelgangerdilemmasglt2imimicstherapeuticcarbohydraterestrictionfoodchoicefirstoverpharma AT mckelveysean thediscordantdoppelgangerdilemmasglt2imimicstherapeuticcarbohydraterestrictionfoodchoicefirstoverpharma AT heseltinethomasd thediscordantdoppelgangerdilemmasglt2imimicstherapeuticcarbohydraterestrictionfoodchoicefirstoverpharma AT hendersongeorge thediscordantdoppelgangerdilemmasglt2imimicstherapeuticcarbohydraterestrictionfoodchoicefirstoverpharma AT singhjagdeep thediscordantdoppelgangerdilemmasglt2imimicstherapeuticcarbohydraterestrictionfoodchoicefirstoverpharma AT unwindavid thediscordantdoppelgangerdilemmasglt2imimicstherapeuticcarbohydraterestrictionfoodchoicefirstoverpharma AT bradyadrianjb thediscordantdoppelgangerdilemmasglt2imimicstherapeuticcarbohydraterestrictionfoodchoicefirstoverpharma AT murrayscottw discordantdoppelgangerdilemmasglt2imimicstherapeuticcarbohydraterestrictionfoodchoicefirstoverpharma AT mckelveysean discordantdoppelgangerdilemmasglt2imimicstherapeuticcarbohydraterestrictionfoodchoicefirstoverpharma AT heseltinethomasd discordantdoppelgangerdilemmasglt2imimicstherapeuticcarbohydraterestrictionfoodchoicefirstoverpharma AT hendersongeorge discordantdoppelgangerdilemmasglt2imimicstherapeuticcarbohydraterestrictionfoodchoicefirstoverpharma AT singhjagdeep discordantdoppelgangerdilemmasglt2imimicstherapeuticcarbohydraterestrictionfoodchoicefirstoverpharma AT unwindavid discordantdoppelgangerdilemmasglt2imimicstherapeuticcarbohydraterestrictionfoodchoicefirstoverpharma AT bradyadrianjb discordantdoppelgangerdilemmasglt2imimicstherapeuticcarbohydraterestrictionfoodchoicefirstoverpharma |